US Patent Issued to Astellas Institute for Regenerative Medicine on Nov. 3 for "Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells" (Massachusetts, Rhode Island, California Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,778,983, issued on Nov. 3, was assigned to Astellas Institute for Regenerative Medicine (Westborough, Mass.).

"Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells" was invented by Christopher Malcuit (Swampscott, Mass.), Linda Lemieux (Hubbardston, Mass.), William Holmes (Worcester, Mass.), Pedro Huertas (Pasadena, Calif.) and Lucy Vilner (Johnston, R.I.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides improved methods for producing retinal pigmented epithelial (RPE) cells from human embryonic stem cells, human induced pluripotent stem (iPS), human adult stem cells, human hematopoietic stem...